These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7889200)

  • 1. Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
    Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Horiuchi M; Katori R
    Blood Press Suppl; 1994; 5():43-8. PubMed ID: 7889200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
    Kawamura M; Terashita Z; Okuda H; Imura Y; Shino A; Nakao M; Nishikawa K
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1664-9. PubMed ID: 8371164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
    Taguchi J; Abe J; Ohno M; Schwartz SM; Kurokawa K
    Blood Press Suppl; 1994; 5():38-42. PubMed ID: 7889199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
    Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Kai T; Horiuchi M
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S360-2. PubMed ID: 9072428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
    Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery.
    Tazawa S; Nakane T; Chiba S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):898-904. PubMed ID: 9918604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephropathy.
    Moriyama T; Kawada N; Akagi Y; Ando A; Horio M; Yamauchi A; Nagata K; Imai E; Hori M
    Kidney Int Suppl; 1997 Dec; 63():S232-5. PubMed ID: 9407468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension.
    Ogihara T; Higashimori K; Masuo K; Mikami H
    Clin Ther; 1993; 15(4):684-91. PubMed ID: 8221818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
    Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
    Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the renin-angiotensin system in hypertension in the elderly.
    Nagano M; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
    Kanno Y; Okada H; Suzuki H; Ikenaga H; Saruta T
    Blood Press Suppl; 1994; 5():67-70. PubMed ID: 7889204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog.
    Miyazaki M; Shiota N; Sakonjo H; Takai S
    Jpn J Pharmacol; 1999 Apr; 79(4):455-60. PubMed ID: 10361885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.
    Abe J; Deguchi J; Matsumoto T; Takuwa N; Noda M; Ohno M; Makuuchi M; Kurokawa K; Takuwa Y
    Circulation; 1997 Sep; 96(6):1906-13. PubMed ID: 9323080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury.
    Miyazaki M; Wada T; Shiota N; Takai S
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S21-5; discussion S33-4. PubMed ID: 10076917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats.
    Nagisa Y; Shintani A; Nakagawa S
    Diabetologia; 2001 Jul; 44(7):883-8. PubMed ID: 11508274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation.
    Okada K; Bernstein ML; Zhang W; Schuster DP; Botney MD
    Am J Respir Crit Care Med; 1998 Sep; 158(3):939-50. PubMed ID: 9731029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
    Shimamoto K; Matsuda K; Takizawa H; Higashiura K; Ura N; Iimura O
    Blood Press Suppl; 1994; 5():113-6. PubMed ID: 7889192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.